Radiofrequency ablation of the pulmonary vein ostia in elderly patients with atrial fibrillation
- 作者: Marinin V.A.1, Sotnikov A.V.1, Stepanova V.V.1, Savelyeva M.A.1, Urazovskaya I.L.1
-
隶属关系:
- North-Western State Medical University named after I.I. Mechnikov
- 期: 卷 4, 编号 3 (2024)
- 页面: 15-24
- 栏目: Original Research
- URL: https://ogarev-online.ru/cardar/article/view/309682
- DOI: https://doi.org/10.17816/cardar640825
- ID: 309682
如何引用文章
详细
BACKGROUND: Restoration and maintenance of sinus rhythm is one of the most important aspects of managing patients with atrial fibrillation. The greatest effectiveness is achieved when this intervention is performed in young patients without comorbidities and in patients with paroxysmal atrial fibrillation. The appropriateness of performing radiofrequency ablation of the pulmonary vein ostia in elderly patients with atrial fibrillation remains a subject of debate.
AIM: to study the immediate and long-term results of catheter ablation in elderly patients with AF.
MATERIALS AND METHODS: The study group consisted of 88 patients aged 75–88 years who underwent RFA of the pulmonary vein ostia. The technique used was classical, with femoral puncture access, and irrigated ablation catheter. Data analyzed included ECG parameters, incidence of systemic thromboembolic complications, functional class of chronic heart failure according to NYHA, subjective state post-procedure, occurrence of atrial fibrillation recurrences, and the impact of baseline clinical factors on disease recurrence.
RESULTS: In 80 patients (90.9%), atrial fibrillation did not recur during their hospital stay after radiofrequency ablation of the pulmonary vein ostia. In the long term (min 1.5, max 3.1 years), a cross-sectional observational study was conducted on 37 patients. Adherence to oral anticoagulants was 97.6%. No systemic thromboembolic events were recorded among the patients available for contact. Atrial fibrillation recurrences troubled 67.6% of patients after radiofrequency ablation. The main predictors of atrial fibrillation recurrence in elderly patients were the presence of hypertension (p=0.03) and baseline left atrial enlargement (p=0.001). Despite the high recurrence rate, there was a significant reduction in the functional class of chronic heart failure following radiofrequency ablation of the pulmonary vein ostia (p=0.009).
CONCLUSIONS: Strict selection is required for performing catheter ablation in patients with atrial fibrillation older than 75 years. Significant left atrial enlargement and uncontrolled hypertension are major limitations for performing RFA of the pulmonary vein ostia in the elderly. The procedure demonstrates significant effectiveness in terms of reducing chronic heart failure functional class in patients over 75 years old, despite the high recurrence rates in the long term.
作者简介
Valery Marinin
North-Western State Medical University named after I.I. Mechnikov
Email: Valerii.Marinin@szgmu.ru
ORCID iD: 0000-0002-8141-5149
SPIN 代码: 3681-6714
MD, Dr. Sci. (Medicine)
俄罗斯联邦, Saint PetersburgArtem Sotnikov
North-Western State Medical University named after I.I. Mechnikov
Email: artem.sotnikov@szgmu.ru
ORCID iD: 0000-0003-1831-7025
SPIN 代码: 4033-1083
MD, Cand. Sci. (Medicine)
俄罗斯联邦, Saint PetersburgVera Stepanova
North-Western State Medical University named after I.I. Mechnikov
Email: veragrokhotova@mail.ru
ORCID iD: 0000-0003-2540-6544
SPIN 代码: 9710-3406
MD, Cand. Sci. (Medicine)
俄罗斯联邦, Saint PetersburgMaria Savelyeva
North-Western State Medical University named after I.I. Mechnikov
编辑信件的主要联系方式.
Email: savelyeva.mariaanat@yandex.ru
ORCID iD: 0009-0008-5667-115X
SPIN 代码: 9935-5416
clinical resident of the 1st year
俄罗斯联邦, Saint PetersburgIrina Urazovskaya
North-Western State Medical University named after I.I. Mechnikov
Email: doc.urazovskaya@gmail.com
ORCID iD: 0000-0003-4165-4599
SPIN 代码: 9263-4316
MD, Cand. Sci. (Medicine)
俄罗斯联邦, Saint Petersburg参考
- Arakelyan MG, Bockeria LA, Vasilieva EYu, et al. 2020 Clinical guidelines for atrial fibrillation and atrial flutter. Russian Journal of Cardiology. 2021;26(7):190–260. doi: 10.15829/1560-4071-2021-4594 EDN: FUZAAD
- Revishvili ASh, Rzaev FG, Dzhordzhikiya TR, et al. Atrial fibrillation in young patients. Annals of Arrhythmology. 2007;4(3):22–28. (In Russ.) EDN: KAMJWL
- Elesin DA, Romanov AB, Turov AN, et al. Radiofrequency ablation of paroxysmal and prolonged persistent atrial fibrillation: one-year follow-up with the use of continuous subcutaneous monitoring. Journal of Arrhythmology. 2011;(63):5–11. EDN: RRQEDH
- Fedorova MH, Chapurnyh AV, Nizhnichenko VB, et al Efficiency and safety of radiofrequency catheter ablation of atrial fibrillation in elderly patients. Journal of Clinical Practice. 2017;(2(30)):34–41. doi: 10.17816/clinpract8234-41 EDN: YLYKMC
- Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Russian Journal of Cardiology. 2021;26(9):234–329. doi: 10.15829/1560-4071-2021-4701 EDN: NNLETB
- Aripova NR, Abdullaeva AA, Zlobina PD, et al. Pathogenesis, predictors and prognostic scales for assessing the risk of reccurence of atrial fibrillation after catheter treatment: a literature review. Siberian Journal of Clinical and Experimental Medicine. 2023;38(4):55–60. doi: 10.29001/2073-8552-2023-38-4-55-60
- Revishvili ASh, Nardaya ShG, Rzaev FG, et al. Electrophysiological and clinical predictors of effectiveness of radiofrequency ablation in the pulmonary veins and left atrium in patients with persistent form of atrial fibrillation. Annals of Arrhythmology. 2014;11(1):46–53. doi: 10.15275/annaritmol.2014.1.6 EDN: QQQYGP
- D'Ascenzo F, Corleto A, Biondi-Zoccai G, et al. Which are the most reliable predictors of recurrence of atrial fibrillation after transcatheter ablation? A meta-analysis. International Journal of Cardiology. 2013;167(5):1984–1989. doi: 10.1016/j.ijcard.2012.05.008
- Kornej J, Hindricks G, Shoemaker MB, et al. The APPLE score: a novel and simple score for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation. Clinical Research in Cardiology. 2015;104(10):871–876. doi: 10.1007/s00392-015-0856-x EDN: WCYZOK
- Cheng M, Lu X, Huang J, et al. Electrocardiographic PR prolongation and atrial fibrillation risk: a meta-analysis of prospective cohort studies. Journal of Cardiovascular Electrophysiology. 2015;26(1):36–41. doi: 10.1111/jce.12539
- Park J, Kim TH, Lee JS, et al. Prolonged PR interval predicts clinical recurrence of atrial fibrillation after catheter ablation. Journal of the American Heart Association. 2014;3(5):e001277. doi: 10.1161/JAHA.114.001277
- Hoffmann E, Straube F, Wegscheider K, et al. Outcomes of cryoballoon or radiofrequency ablation in symptomatic paroxysmal or persistent atrial fibrillation. Europace. 2019;21(9):1313–1324. doi: 10.1093/europace/euz155 EDN: RCDWFG
- Al-Khatib SM, Allen LaPointe NM, Chatterjee R, et al. Rate- and rhythm-control therapies in patients with atrial fibrillation: a systematic review. Ann Intern Med. 2014;160(11):760–773. doi: 10.7326/M13-1467
- Chatterjee S, Sardar P, Lichstein E, et al. Pharmacologic rate versus rhythm-control strategies in atrial fibrillation: an updated comprehensive review and meta-analysis. Pacing Clin Electrophysiol. 2013;36(1):122–133. doi: 10.1111/j.1540-8159.2012.03513.x
- Packer DL, Mark DB, Robb RA, et al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA. 2019;321(13):1261–1274. doi: 10.1001/jama.2019.0693 EDN: MQXJXB
- Lukina YuV, Kutishenko NP, Tolpygina SN, et al. Main factors of adherence to new oral anticoagulants and its dynamics in outpatients with nonvalvular atrial fibrillation: results of the ANTEY study. Cardiovascular Therapy and Prevention. 2020;19(5):2680. doi: 10.15829/1728-8800-2020-2680 EDN: TUKQLM
- Garkina SV, Vavilova TV, Lebedev DS, et al. Compliance and adherence to oral anticoagulation therapy in elderly patients with atrial fibrillation in the era of direct oral anticoagulants. Journal of Geriatric Cardiology. 2016;13(9):807–810. doi: 10.11909/j.issn.1671-5411.2016.09.010 EDN: WXVYMR
- Packer DL, Piccini JP, Monahan KH, et al. Ablation versus drug therapy for atrial fibrillation in heart failure: results from the CABANA Trial. Circulation. 2021;143(14):1377–1390. doi: 10.1161/CIRCULATIONAHA.120.050991 EDN: FMSQQX
补充文件
